Considering the differences between PDTCs and ATCs, it has been reported that ATCs show significantly higher frequencies of TP53, TERT promoter, PIK3CA and PTEN mutations compared to PDTCs [30,31]. This evidence concerns the gene TP53 and Ehlers-Danlos syndrome, musculocontractural type.